Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay

AIDS Research and Human Retroviruses

Volumn 12, Issue 9, 1996, Pages 811-820

  Moir, Susan ^b   Poulin, Louise ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; VIRUS GLYCOPROTEIN;

ARTICLE; CELL FUSION; CELL SURFACE; ENVELOPE GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE;

EID: 0029941282     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.811     Document Type: Article

References (51)

1. Dalgleish AG, Beverly PC, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-767.
2. Klatzmann D, Champagne E, Chamaret S, Gurest J, Guetard D, Hercend T, Gluckman JC, and Montagnier L: T-lymphocyte T4 molecule behaves as a receptor for human retrovirus LAV. Nature (London) 1984;312:767-771.
3. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine W, and Sodroski J: Functional regions of the envelope glycoprotein of the human immunodeficiency virus type 1. Science 1987;237:1351-1355.
4. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50:975-985.
5. Dedera D and Ratner L: Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. J Virol 1991;65:6129-6136.
6. Freed EO, Myers DJ, and Risser R: Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci USA 1990;87: 4650-4654.
7. Helseth E, Kowalski M, Gabuzda D, Olshevsky U, Haseltine W, and Sodroski J: Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol 1990;64:2416-2420.
8. Phillips DM: The role of cell-to-cell transmission in HIV infection. AIDS 1994;8:719-731. [Editorial].
9. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
10. Moore JP: A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1. J Virol 1993;67:3656-3659.
11. Dimitrov DS, Golding H, and Blumenthal R: Initial steps in HIV-1 envelope glycoprotein mediated cell fusion monitored by a new assay based on redistribution of fluorescence markers. AIDS Res Hum Retroviruses 1991;7:799-805.
12. Kimpton J and Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 1992;66:2232-2239.
13. Dragic T, Chameau P, Clavel F, and Alizon M: Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol 1992;66:4794-4802.
14. Tang SB and Levy JA: Parameters involved in the cell fusion induced by HIV. AIDS 1990;4:409-415.
15. Ahmad A, Ladha A, Cohen EA, and Menezes J: Stable expression of the transfected HIV-1 env gene in a human B cell line: Characterization of gp120-expressing clones and immunobiological studies. Virology 1993;192:447-457.
16. Berman PW, Nunes WM, and Haffar OK: Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines. J Virol 1988;62:3135-3142.
17. Chakrabarti S, Robert-Guroff M, Wong-Staal F, Gallo RC, and Moss B: Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature (London) 1986;320:535-537.
18. Chanda PK, Natuk RJ, Mason BB, Bhat BM, Greenberg L, Dheer SK, Molnar-Kimber KL, Mizutani S, Lubeck MD, Davis AR, and Hung PP: High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in the presence of rev gene using helper independent adenovirus type 7 recombinants. Virology 1990;175:535-547.
19. Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JA, McClure MO, Thomson S, Marsh M, Kay J, Weiss RA, and Moore JP: The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: A possible function in viral fusion? AIDS Res Hum Retroviruses 1991;7:3-16.
20. Dewar RL, Vasudevachari MB, Natarajan V, and Salzman NP: Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: Effects of monensin on glycosylation and transport. J Virol 1989;63:2452-2456.
21. Paul NL, Marsh M, McKeating JA, Schulz TF, Liljestrom P, Garoff H, and Weiss RA: Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors. AIDS Res Hum Retroviruses 1993;9:963-970.
22. Tani Y, Tian H, Lane HC, and Cohen DI: Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. J Immunol 1993;151:7337-7348.
23. Weiss CD and White JM: Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J Virol 1993;67:7060-7066.
24. Bour S, Boulerice F, and Wainberg MA: Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J Virol 1991;65:6387-6396.
25. Crise B, Buonocore L, and Rose JK: CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol 1990;64:5585-5593.
26. Hammarskjold ML, Heimer J, Hammarskjold B, Sangwan I, Albert IO, and Rekosh D: Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol 1989;63:1959-1966.
27. York-Higgins D, Cheng-Mayer C, Bauer D, Levy JA, and Dina D: Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J Virol 1990;64:4016-4020.
28. Kunkel TA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985;82:488-492.
29. Johansen TE, Scholler MS, Tolstoy S, and Schwartz TW: Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett 1990;267:289-294.
30. Lu XB, Heimer J, Rekosh D, and Hammarskjold ML: U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci USA 1990;87:7598-7602.
31. Burkly L, Murley N, Blumenthal R, and Dimitrov DS: Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies. J Virol 1995;69:4267-4273.
32. Bazin R, Darveau A, Martel F, Pelletier A, Piché L, St-Laurent M, Thibault L, Demers A, Boyer L, Lemieux G, and Lemieux R: Increased avidity of mutant IgM antibodies caused by the absence of COOH-terrninal glycosylation of the μ H chain. J Immunol 1992;149:3889-3893.
33. Chang DD and Sharp PA: Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989;59:789-795.
34. Jeang KT, Chang Y, Berkhout B, Hammarskjold ML, and Rekosh D: Regulation of HIV expression: Mechanisms of action of Tat and Rev. AIDS 1991;5:S3-S14.
35. Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, and Wong-Staal F: The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 1987;237:888-893.
36. Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, and Bolognesi DP: HIV-1 gp120-mediated immune suppression and lymphocyte destruction in absence of viral infection. J Immunol 1989;142:3091-3097.
37. Pleskoff O, Seman M, and Alizon M: Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: Effect on virus-cell fusion but not on cell-cell fusion. J Virol 1995;69:570-574.
38. Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley PC, and Sattentau QJ: Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med 1990;172:1233-1242.
39. Rekosh D, Nygren A, Flodby P, Hammarskjold M, and Wigzell H: Coexpression of human immunodeficiency virus envelope glycoproteins and Tat from a single simian virus 40 late replacement vector. Proc Natl Acad Sci USA 1988;85:334-338.
40. Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjold ML, Potts B, Murray M, Putney SD, and Gray G: Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol 1992;66: 1875-1883.
41. Thali M, Olshevsky U, Furman C, Gabuzda D, Li J, and Sodroski J: Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J Virol 1991;65:5007-5012.
42. Jonak ZK, Clark RK, Matour D, Trulli S, Craig R, Henri E, Lee EV, Greig R, and Debouck C: A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope. AIDS Res Hum Retroviruses 1993;9:23-32.
43. Ahmad A, Yap XA, Tanner JE, Cohen E, and Menezes J: Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: Characterization and killing by an antibody-dependent cellular cytotoxic mechanism. J Acquir Immune Defic Syndr 1994;7:789-798.
44. Schwartz S, Felber BK, and Pavlakis GN: Mechanism of translation of monocistronic and multicistronic human immunodeficiency deficiency virus type 1 mRNAs. Mol Cell Biol 1992; 12:207-219.
45. Schwartz S, Felber BK, Fenyö EM, and Pavlakis GN: Env and Vpu proteins of human immunodeficiency virus are produced from multiple bicistronic mRNAs. J Virol 1990;64:5448-5456.
46. Poulin L, Evans LA, Tang SB, Barboza A, Legg H, Littman DR, and Levy JA: Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J Virol 1991;65: 4893-4901.
47. Sato H, Orenstein J, Dimitrov D, and Martin M: Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 1992;186:712-724.
48. Burkly LC, Olson D, Shapiro R, Winkler G, Rosa JJ, Thomas DW, Williams C, and Chisholm P: Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol 1992;149:1779-1787.
49. Dragic T, Picard L, and Alizon M: Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1995;69:1013-1018.
50. Yahi N, Fantini J, Mabrouk K, Tamalet C, de MP, van RJ, Rochat H, and Sabatier JM: Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages. J Virol 1994;68:5714-5720.
51. Earl PL, Koenig S, and Moss B: Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoproteins: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J Virol 1991; 65:31-41.